AOD-9604

Advanced Obesity Drug 9604

Also known as: HGH Fragment 176-191

Low Risk

Fat Loss

A 16-amino acid fragment of HGH designed to harness fat-burning properties without broader growth effects. Note: largest clinical trial failed to show statistical significance.

Benefits

Stimulates fat cell metabolism (lipolysis, animal data)

Inhibits new fat formation (lipogenesis, animal data)

Maintains normal glucose homeostasis

No effect on blood sugar or growth

Side Effects & Risks

Injection site reactionsmild

Headachemild

Mild nauseamild

Dosing Information

Typical Dose

250-500 mcg daily (SC)

Administration

Subcutaneous injection (abdomen, empty stomach)

Cycle Length

8-12 weeks

Notes

Note: clinical trials used ORAL dosing (1-30mg), not the injectable SC dose commonly promoted online. Injectable dosing is not clinically validated.

Legal Status

FDA Status

Not FDA-approved; Phase IIb trial failed 2007

Availability

Removed from Category 2 Sept 2024; some compounding pharmacies

WADA Status

Banned by WADA (athletes beware)

Evidence

Evidence LevelLow-Moderate

6 human clinical trials (oral), 900+ participants. Largest Phase IIb FAILED statistical significance. Development terminated. "Muscle preservation" claim has no published evidence. Popular despite weak evidence.

Works Well In These Stacks

Body Recomp

Simultaneous muscle gain and fat loss

CJC-1295IpamorelinAOD-9604

Where to Buy

Available from verified suppliers

BiosynTech Research Verified4.5

View Supplier

AOD-9604 Economy Vial

LyophilizedPurity: 98%+

COA Available Third-Party TestedIn Stock

MetaVitality Labs Verified4.7

View Supplier

AOD-9604 Fat Metabolism Peptide

LyophilizedPurity: 99%+

COA Available Third-Party TestedIn Stock